FDA Approves Darolutamide for Metastatic Castration-Sensitive Prostate Cancer By Ogkologos - June 27, 2025 171 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the ARANOTE study Source RELATED ARTICLESMORE FROM AUTHOR ESMO’s Special Consultative Status with United Nations Economic and Social Council (UN ECOSOC) Confirmed Until 2028 EMA Recommends Extension of Indications for Selumetinib ESMO Calls for Urgent Changes to the in Vitro Diagnostic Medical Devices Regulation (IVDR) in Order to Safeguard Cancer Research in Europe MOST POPULAR Ribociclib Approval Expanded for Some Women with Advanced Breast Cancer August 20, 2018 4-Year-Old Secretly Told Teacher His Dad Was Sick, And She Donated... September 4, 2019 What People With Cancer and Survivors Should Know About Vaping: An... September 26, 2023 A new approach to cancer immunotherapy March 18, 2022 Load more HOT NEWS Popular Fitness Instructor Encourages Others to Maintain Routine Check Ups After... Breast Cancer Survivor Fights Back After Instagram Bans Photos of Her... Pediatric MATCH Study Finds More Targetable Genetic Changes than Expected News digest – cancer blood test, gum disease and junk food...
